ERASE STUDY

Exercise during Active Surveillance for Prostate Cancer

February 17, 2022

The ERASE Trial found that high-intensity interval training (HIIT) reduced prostate cancer-related anxiety and fear of cancer progression in prostate cancer patients on active surveillance. These findings are now published in the top urology journal, Journal of Urology, with an editorial, stating that "a remarkable prospective trial of men on active surveillance underscores the importance of addressing psychological concerns of our patients, and suggests there are potential interventions we can offer"

 

A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance

 

*Editorial: Prostate Cancer, Decisional Regret and Exercise

 

August 21, 2021

The primary findings of ERASE Trial highlight that high-intensity interval training (HIIT) improved cardiorespiratory fitness and suppressed the biochemical progression of prostate cancer in men undergoing active surveillance. These findings are now published in one of the top oncology journals, JAMA Oncology, with an accompanying editorial, and have been featured in numerous medical new media.

 

Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active SurveillanceThe ERASE Randomized Clinical Trial 

 

*Editorial: The Power of Exercise to Influence Cardiovascular and Oncologic Outcomes—Survival of the Fittest

WHAT CAN EXERCISE DO FOR MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE?

Active surveillance is a way of monitoring prostate cancer and is increasingly the therapy of choice for men with localized, slow-growing tumours, allowing them to delay or avoid treatment and the side effects that can occur after surgery and radiotherapy.

 
If our hypothesis is correct, exercise could be a cost-effective and simple way for men on active surveillance to feel better, slow cancer progression and delay or eliminate medical treatment altogether.

 

 

PROSTATE CANCER CANADA'S
STEP-UP CHALLENGE FUNDRAISER
EDMONTON

Funds raised towards the ERASE Study

2018: $78,000

2019: $58,000 

Funded by

Picture2.png
Picture1.png
Picture3.jpg